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Abstract 
 Tubal blockage is one of the most essential causative factors for female infertility. It is the need of the era 
that a secure, more expenditure effectual and absolute therapy of this sensitive problem should be developed. This 
review study is an attempt to evaluate the efficacy of Kumari Taila Uttarabasti in tubal blockage. Patients of child 
bearing age with active marital life of 1 year or more having complaint of failure to conceive with at least one 
fallopian tube blocked diagnosed by Hysterosalpingography (HSG) were selected. The data of Total four studies of 
different scholars has been taken for review is being presented here. Out of total 67 registered patients, 61 patients 
completed the course of treatment, with 53.73% unilateral and 46.27% bilateral tubal blockage. Kumari Taila (5 
ml) Intrauterine Uttarabasti was given for 6 days (with interval of three days in between), after completion of 
menses for two consecutive cycles. The tubal patency was found in 62.69% of patients and conception was 
achieved in 20.90% without any complication. Uttarabasti is an imperative and an exclusive Ayurvedic procedure 
stated in classics particularly for the management of Vandhyatva and other gynecological disorders. Kumari Taila 
Uttarabasti is a highly effective procedure for treating tubal blockage with no apparent evidence of complication.  
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Introduction 
 Infertility is the failure to conceive (regardless of 
cause) after one year of unprotected intercourse. It 
affects approximately 10-15% of reproductive aged 
couples. Among the responsible factors of female 
infertility, tubal blockage is the second highest i.e. 25-
35% and one of the most notorious factors and very 
difficult to treat.(1) The management alternatives for it 
are only tubal reconstructive surgeries and In vitro 
fertilization (IVF) and available in a very few infertility 
clinics in developing countries which are not easily 
accessible. Probability of ectopic pregnancy and other 
complications are also there. On the other hand, no one 
has established any reliable Ayurvedic treatment for 
the tubal blockage. Eventhough, Ayurvedic 
practitioners assert the effect of intra uterine Uttarbasti 
on tubal blockage. Hence it was planned that the 
review study of four research works from I.P.G.T. and 
R.A., Jamnagar has been done for establishing a 
significant data based treatment regimen for tubal 
blockage through Ayurveda. 
 
Aims and objectives 
 This review study is an attempt to evaluate the 
efficacy of Kumari Taila Uttarabasti in the management 
of fallopian tubal blockage. 
 
Materials and Methods 
 Patients attending the O.P.D. of Stree Roga & 
Prasooti Tantra department, fulfilling the criteria for 
selection were incorporated into the study irrespective 
of caste, religion etc. A special research proforma was 
prepared. Total four research works have been reported 
in I.P.G.T. & RA, Jamnagar. From them, Total 67 
patients were registered, out of them 61 patients 
completed the course of treatment. All the patients were 
examined per vaginally to assess any sign of infection 
or disorder related to tubal infertility. 
 
Criteria for selection of cases 
Inclusion criteria:  
Patients of child bearing age having complaints of 
failure to conceive due to tubal blockage were selected 
for the study, on the diagnostic basis of 
Hysterosalpingography (HSG) for minimizing the 
chances of false positive reports. 
 
Published online in http://ijam. co. in 
198 
Hetal P Baraiya et.al., Management of Vandhyatva with Uttaravasti 
ISSN: 0976-5921 
Exclusion criteria:  
Patients with any possibility of active urogenital 
infections, history of excessive menstruation, suffering 
from any chronic disease, Hepatitis B, sexually 
transmitted disease, human immunodeficiency virus 
(HIV), contagious diseases etc. were excluded. 
 
Investigations:  
Serological tests for HIV (Human 
Immunodeficiency Virus), HBsAg (Australia antigen 
for hepatitis B) & VDRL (Venereal Disease Research 
Laboratory) were carried out in all the patients before 
starting the course of treatment.  
Transvaginal sonography was done before 
treatment to rule out any pelvic pathology.  
Routine haematological and urine investigations 
were done before and after treatment. 
 
Selection of drug  
 Tubal blockage has been considered as the Vata 
predominant Tridoshaja condition, with Kapha as being 
the next Dosha, as Vata was responsible for Sankocha,
(2)  Kapha for Shopha and Puya while Pitta for Paka.
(3) Thus, all the three Doshas are collectively 
responsible for the stenosis or the hampering type of 
pathology of the fallopian tubes. The drug assumed as 
effective to open the fallopian tube was considered to 
have Tridoshaghna properties mainly 
Vatakaphashamaka. Local administration of any drug 
which containing Sukshma, Laghu, Sara, Vyavayi, 
Vikasi, Pramathi etc. Guna; Katu Vipaka & Ushna 
Virya can be assumed to have some effective role in 
removing tubal blockage and to restore the tubal 
functions by reaching up to the minute channels. It is 
mentioned for Vata Kaphaja Shiroroga.(4) It includes 
various drugs effective in gynaecological disorders. 
Several contents of Kumari Taila are highly efficacious 
& established for their role in menstrual disorders and 
hormonal imbalance. 
 
Treatment protocol 
 Uttarbasti of Kumari Taila (five milliliters) was 
given for six days (with interval of three days in 
between), after cessation of menses for two consecutive 
cycles,(5) with the consent of the patient. Snehana 
(oleation) of Bala Taila(6) followed by Nadi Sveda 
(fomentation) with water steam was done on the lower 
abdomen, back and lower limbs to the patients, before 
each Uttarbasti. For sterilization of peri vaginal part 
Yoni Prakshalana with Panchavalkala Kvatha(7) was 
performed. The procedure was carried out in the 
operation theatre with all antiseptic and aseptic 
precautions and then the patient was kept in head low 
for two hours. The lower abdomen was fomented with 
hot water bag. The HSG was repeated for the analysis of 
results after the cessation of menstruation in third cycle. 
 
Precautions  
 The patients were asked to avoid very spicy food 
during treatment. Coitus was prohibited during the 
course of Uttarabasti. Proper care was taken for not 
allowing patients to suffer from constipations.  
 
Assessment of complications  
 The chances of complications cannot be ignored 
totally, because the Taila prepared with Ushna-Tikshna 
Dravyas was administered inside the uterus. Lower 
abdominal pain and per vaginal bleeding were the most 
apparent complaints during and after procedure. It was 
considered as complication, only if it is was very much 
irritating for the patient. Any type of features of 
urogenital infection during and after procedure was 
considered as complication. Hence, close study was 
kept to detect complications as early as possible. 
 
End points of the treatment  
 If the patient conceives in between the course of 
study.  
 If features of any type of urogenital infections are 
observed.  
 If heavy per vaginal bleeding creates.  
 If there occurs severe abdominal pain, which 
troubles the patient to a great extent.  
 
Follow-up study  
 Follow-up study for pregnancy or any late 
complication was carried out for two months after the 
completion of treatment. Any new complaint appears 
during follow up period related to study was also noted. 
 
Observations and Results (8),(9),(10),(11): 
 
Chart 1. Types of Infertility (N=67) 
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Chart 2. Types of Tubal Blockage(N=67) 
 
 
 
Chart 3. Tubal Patency after Uttarabasti (N=61) 
 
 
  
Chart 4. Patients, who conceived within follow up 
period (N=61) 
 
 
Discussion 
 While considering the history of infertility, the 
62.69% patients were found with the primary infertility 
[Chart 1]. It is a trend in many gynecology clinics that 
tubal blockage is evaluated at last after long term of 
ovulation induction and other treatment. But, this data 
shows the change in trend, at least in our institution 
where tubal factor is given prime importance as 
preliminary investigation. It also disproves the general 
belief that some infection during previous labour or 
abortion is the major cause of tubal blockage. Since 
tubal blockage is quite prevalent even in patients with 
primary infertility, it should not be neglected and must 
be evaluated after some cycles of treatment before 
allowing the condition to get much complicated due to 
several inductions. There was not much significant 
difference observed in unilateral & bilateral tubal 
blockage. The incidence of unilateral & bilateral tubal 
blockage in the present study shows the prevalence of 
both the conditions high in the society [Chart 2]. Yet 
unilateral blockage is also important to give due 
consideration, because, it reduces the possibility of 
conception. And the condition becomes worse, if 
another patent tube is not normal physiologically. The 
contractile response was confirmed by the lower 
abdominal pain, which was a common complaint after 
procedure. No patient had excessive or fresh bleeding. 
It proves the removal of the inner uterine as well as 
tubal lining by the Ushna-Tikshna and Lekhana 
properties of drugs. Symptoms of genitourinary 
infection and oil embolism were not reported during 
and after procedure and even in the follow up period in 
any patient of four research works, which is the most 
probable complication of Uttarabasti. It was because of 
the potent anti-inflammatory and anti-infective effect of 
Tila Taila which is used as a vehicle in the drug. It 
proves the intra uterine Uttarabasti as a safe therapeutic 
measure against tubal blockage. Tubal blocks were 
removed in 62.69% patients and conception was 
achieved in 20.90% patients within the follow-up 
period [Chart 3-4]. This total effect of therapy was very 
encouraging and highly significant on tubal blockage. It 
shows the potency of the drugs used and also the 
efficacy of Uttarabasti. Conception rate is less as it is a 
problem involving multiple factors like anovulation, 
PCOD, male factors etc. Most of the patients had taken 
exclusively Allopathic treatment. History of D and C or 
D and E was found in less than 40% patients. The most 
common site was Cornual block in all four studies. 
 
Probable mode of action of intra uterine Uttarabasti 
on tubal blockage  
 All three Doshas are involved in the pathogenesis 
of tubal block with predominance of Vata Dosha. 
Kapha is also one of the responsible factors for 
vitiation of Vata due to its Avarodhatmaka Guna. Vata 
vitiated on its own as well as by Kapha which is able to 
vitiated Vata by its property to cause Avarodha. For 
administration of the drug in tubal blockage, a medium 
is always required. The medium adapted must not be 
having any adverse effect in Samprapti V ighatana and 
it would be more appreciable, if it will contain some 
adjuvant role to open tubal blockage. So, Tila Taila was 
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selected for this purpose, as it has most of the qualities, 
which were required for the present study. Several 
contents of Kumari Taila are highly efficacious & 
established for their role in menstrual disorders and 
hormonal imbalance. In case of tubal blockage, effect 
seems to be more local than systemic. The Tila Taila
(12),(13),(14),(15) is Vranashodhaka & Vranapachaka. 
It is Krimighna too. In addition, its specific role on 
uterus and reproductive tract is also mentioned as 
Garbhashayashodhana & Yonishulaprashamana. These 
all the properties indicate towards its antiseptic as well 
as anti-inflammatory actions. Its Vyavayi & Vikasi 
Guna show its potency to enter in minute channels and 
to get spread easily. Thus, it should be the best medium 
for any drug to reach in tubal cavity and remove the 
blockage. Kumari (Aloe vera) (16),(17),(18) is now well 
established for its anti-inflammatory, ulcer-healing and 
antibacterial properties. It is Tikshna and Vata-
Kaphavardhaka in Karma. Thus, it removes the fibrosis 
of endometrium and helps in its rejuvenation. Its Anti-
inflammatory action decreases the inflammation and 
ulcer-healing property heals the inner lining of tubes and 
uterus. The another important content of Kumari Taila, 
Bhringaraja (Eclipta alba) (19) is a very potent Vata-
Kapha Shamaka drug, which contains antiviral, 
antibacterial, antioxidant and antihaemorrhagic 
qualities. All these properties make the medicine more 
potent in removing the chronic inflammation and 
fibrosis. Its Shothahara & Vishahara Karma reduce 
swelling and oedema of the tube and render it in a 
healthier atmosphere. Another major content of Kumari 
Taila, Dhatura (Datura metel) (20),(21),(22) is 
Krimighna, Vranahara & Vishaghna. It is known for its 
anti-inflammatory property and hence, it hastens the 
healing and rejuvenation of the inner lining of tubes. 
 
Conclusion 
 The results suggest that Uttarabasti is a safe, 
reliable & efficacious measure in management of tubal 
infertility. Kumari Taila is a highly effective to achieve 
the patency of fallopian tubes. Chances of complications 
are negligible, if proper antiseptic and aseptic care is 
taken before, during & after the procedure. Rate of 
conception within follow up period shows high chances 
of pregnancy, if other factors are normal. 
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